Page last updated: 2024-10-24

regulation of glutathione biosynthetic process

Definition

Target type: biologicalprocess

Any process that modulates the frequency, rate or extent of glutathione biosynthetic process. [GO_REF:0000058, GOC:bf, GOC:PARL, GOC:TermGenie]

Glutathione (GSH) is a tripeptide (γ-glutamylcysteinylglycine) that plays a crucial role in cellular detoxification, antioxidant defense, and redox regulation. Its biosynthesis involves a two-step enzymatic process:

1. **γ-Glutamylcysteine synthetase (γ-GCS)** catalyzes the condensation of glutamate and cysteine to form γ-glutamylcysteine. This step is the rate-limiting step in GSH synthesis and is subject to tight regulation.

2. **Glutathione synthetase** then adds glycine to γ-glutamylcysteine to form GSH.

**Regulation of Glutathione Biosynthetic Process:**

**1. Transcriptional Regulation:**
- **Nrf2:** The nuclear factor erythroid 2-related factor 2 (Nrf2) is a key transcription factor that regulates the expression of genes involved in GSH biosynthesis, including γ-GCS. Nrf2 is activated in response to oxidative stress, electrophilic compounds, and other stimuli. Once activated, Nrf2 translocates to the nucleus and binds to antioxidant response elements (AREs) in the promoter regions of target genes, leading to increased transcription of these genes.
- **Other Transcription Factors:** Other transcription factors, such as AP-1, NF-κB, and Sp1, also play a role in regulating γ-GCS gene expression.

**2. Post-Translational Modification:**
- **Phosphorylation:** γ-GCS can be phosphorylated by kinases such as protein kinase C (PKC) and AMP-activated protein kinase (AMPK), which can either activate or inhibit its activity depending on the specific kinase involved.
- **S-glutathionylation:** γ-GCS can also be modified by S-glutathionylation, a reversible process involving the attachment of GSH to cysteine residues in the protein. S-glutathionylation can modulate the activity of γ-GCS and other enzymes involved in GSH metabolism.

**3. Substrate Availability:**
- **Cysteine:** Cysteine is the limiting substrate for GSH biosynthesis, as its availability can influence the rate of GSH synthesis.
- **Glutamate:** Glutamate is readily available in most cells.

**4. Feedback Inhibition:**
- **GSH:** GSH itself can feedback inhibit the activity of γ-GCS, preventing excessive accumulation of GSH in the cell.

**5. Other Factors:**
- **Cellular Redox State:** The cellular redox state can influence GSH synthesis by affecting the activity of key enzymes involved in the process.
- **Hormonal Regulation:** Hormones such as insulin, growth hormone, and glucocorticoids can modulate GSH biosynthesis.

**6. Nutritional Factors:**
- **Dietary intake of cysteine and glutamate:** Adequate dietary intake of these amino acids is essential for maintaining GSH levels.
- **Antioxidant intake:** Consumption of antioxidants such as vitamins C and E can indirectly enhance GSH synthesis by reducing oxidative stress and promoting Nrf2 activation.

**Overall, the regulation of GSH biosynthesis is a complex and tightly controlled process involving multiple levels of regulation, ensuring that appropriate levels of GSH are maintained to protect cells from oxidative damage and maintain redox homeostasis.**'
"

Proteins (1)

ProteinDefinitionTaxonomy
Cystine/glutamate transporterA cystine/glutamate transporter that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9UPY5]Homo sapiens (human)

Compounds (9)

CompoundDefinitionClassesRoles
mesalaminemesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
amino acid;
aromatic amine;
monocarboxylic acid;
monohydroxybenzoic acid;
phenols
non-steroidal anti-inflammatory drug
sulfapyridinesulfapyridine : A sulfonamide consisting of pyridine with a 4-aminobenzenesulfonamido group at the 2-position.

Sulfapyridine: Antibacterial, potentially toxic, used to treat certain skin diseases.
pyridines;
substituted aniline;
sulfonamide;
sulfonamide antibiotic
antiinfective agent;
dermatologic drug;
drug allergen;
environmental contaminant;
xenobiotic
sulfasalazinesulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
cysteinecysteine;
cysteine zwitterion;
L-alpha-amino acid;
proteinogenic amino acid;
serine family amino acid
EC 4.3.1.3 (histidine ammonia-lyase) inhibitor;
flour treatment agent;
human metabolite
quisqualic acidQuisqualic Acid: An agonist at two subsets of excitatory amino acid receptors, ionotropic receptors that directly control membrane channels and metabotropic receptors that indirectly mediate calcium mobilization from intracellular stores. The compound is obtained from the seeds and fruit of Quisqualis chinensis.non-proteinogenic alpha-amino acid
serine o-sulfateL-serine O-sulfate : A non-proteinogenic L-alpha-amino acid that is the O-sulfo derivative of L-serine.

serine O-sulfate: RN given refers to (L)-isomer
L-serine derivative;
non-proteinogenic L-alpha-amino acid;
O-sulfoamino acid
homocysteic acidhomocysteic acid : A non-proteinogenic alpha-amino acid that is homocysteine in which the thiol group has benn oxidised to the corresponding sulfonic acid.

homocysteic acid: promotes growth in hypophysectomized rats; RN given refers to parent cpd

L-homocysteic acid : A homocysteic acid with L-configuration.
homocysteic acidNMDA receptor agonist
susalimodsusalimod: analogue of sulphasalazine, was designed for use in the treatment of rheumatoid arthritis
erastinerastin : A member of the class of quinazolines that is quinazolin-4(3H)-one in which the hydrogens at positions 2 and 3 are replaced by 1-{4-[(4-chlorophenoxy)acetyl]piperazin-1-yl}ethyl and 2-ethoxyphenyl groups, respectively. It is an inhibitor of voltage-dependent anion-selective channels (VDAC2 and VDAC3) and a potent ferroptosis inducer.

erastin: an antineoplastic agent; structure in first source
aromatic ether;
diether;
monochlorobenzenes;
N-acylpiperazine;
N-alkylpiperazine;
quinazolines;
tertiary carboxamide
antineoplastic agent;
ferroptosis inducer;
voltage-dependent anion channel inhibitor